Cellular redox, cancer and human papillomavirus.

High-risk Human Papillomavirus (HR-HPV) is the causative agent of different human cancers. A persistent HR-HPV infection alters several cellular processes involved in cell proliferation, apoptosis, immune evasion, genomic instability and transformation. Cumulative evidence from past studies indicates that HR-HPV proteins are associated with oxidative stress (OS) and has been proposed as a risk factor for cancer development. Reactive oxygen and nitrogen species (RONS) regulate a plethora of processes inducing cellular proliferation, differentiation and death. Oxidative stress (OS) is generated when an imbalance in the redox state occurs due to deregulation of the oxidant and antioxidant systems, which, in turn, promotes the damage of DNA, proteins and lipids, allowing the accumulation of mutations and genome instability. OS has been associated with the establishment and development of different cancers, and it has recently been proposed as a co-factor in cervical cancer development. This review is focused on evidence regarding the association of OS with HR-HPV proteins, and the interplay of the viral proteins with different elements of the antioxidant and DNA damage response (DDR) systems, emphasizing the processes that might be required for the viral life cycle and viral DNA integration into the host genome, which is a key element in the carcinogenic process induced by HR-HPV.

[1]  M. Gillison,et al.  Clinical implications of human papillomavirus in head and neck cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Hypoxia and oxidative stress in breast cancer: Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer , 2001, Breast Cancer Research.

[3]  M. Picardo,et al.  Human Papillomavirus-16 E7 Interacts with Glutathione S-Transferase P1 and Enhances Its Role in Cell Survival , 2009, PloS one.

[4]  Miranda Thomas,et al.  The role of the E6-p53 interaction in the molecular pathogenesis of HPV , 1999, Oncogene.

[5]  N. Coleman,et al.  An increase in DNA double‐strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events , 2007, The Journal of pathology.

[6]  K. Münger,et al.  Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. , 2001, Cancer research.

[7]  P. Storz,et al.  Reactive oxygen species in cancer , 2010, Free radical research.

[8]  R. Nagler,et al.  Salivary analysis in oral cancer patients , 2007, Cancer.

[9]  Siti Aishah Md Ali,et al.  Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[10]  H. Çelik,et al.  The interaction between antioxidant status and cervical cancer: A case control study , 2011, Tumori.

[11]  J. Doorbar The E4 protein; structure, function and patterns of expression. , 2013, Virology.

[12]  L. Banks,et al.  The Human Papillomavirus E6 protein and its contribution to malignant progression , 2001, Oncogene.

[13]  Rui Wang,et al.  Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. , 2008, Biochemical and biophysical research communications.

[14]  Cary A Moody,et al.  Human papillomavirus oncoproteins: pathways to transformation , 2010, Nature Reviews Cancer.

[15]  S. Thorgeirsson,et al.  Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer. , 2004, Journal of hepatology.

[16]  D. Lowy,et al.  Efficient Intracellular Assembly of Papillomaviral Vectors , 2004, Journal of Virology.

[17]  J. Hanover,et al.  Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. , 2008, The American journal of pathology.

[18]  P. Duerksen-Hughes,et al.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. , 2011, Future virology.

[19]  A. Sancar,et al.  Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.

[20]  F. Rösl,et al.  The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. , 2002, Cancer letters.

[21]  A. Vlahou,et al.  Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis , 2017, BioMed research international.

[22]  B. Snel,et al.  Evolutionary acquisition of cysteines determines FOXO paralog-specific redox signaling. , 2015, Antioxidants & redox signaling.

[23]  L. Laimins,et al.  Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint , 1998, Journal of Virology.

[24]  B. Halliwell,et al.  Biochemistry of oxidative stress. , 2007, Biochemical Society transactions.

[25]  E. Thorland,et al.  Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. , 2000, Cancer research.

[26]  Zhi-Ming Zheng,et al.  Papillomavirus genome structure, expression, and post-transcriptional regulation. , 2006, Frontiers in bioscience : a journal and virtual library.

[27]  T. Finkel,et al.  Cellular mechanisms and physiological consequences of redox-dependent signalling , 2014, Nature Reviews Molecular Cell Biology.

[28]  E. Passegué,et al.  DNA-damage response in tissue-specific and cancer stem cells. , 2011, Cell stem cell.

[29]  Polycarpos Pissis,et al.  Role of oxidative stress and DNA damage in human carcinogenesis. , 2011, Mutation research.

[30]  D. Butterfield,et al.  Oxidative Stress in HPV-Driven Viral Carcinogenesis: Redox Proteomics Analysis of HPV-16 Dysplastic and Neoplastic Tissues , 2012, PloS one.

[31]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[32]  J. Archambault,et al.  The E1 proteins. , 2013, Virology.

[33]  J. Gunaratne,et al.  Localization of HPV-18 E2 at Mitochondrial Membranes Induces ROS Release and Modulates Host Cell Metabolism , 2013, PloS one.

[34]  H. Ahsan,et al.  Reactive oxygen species: role in the development of cancer and various chronic conditions , 2006, Journal of carcinogenesis.

[35]  Brian J. Smith,et al.  Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma. , 2008, Free radical biology & medicine.

[36]  M. von Knebel Doeberitz,et al.  Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions , 2013, International journal of cancer.

[37]  K. Münger,et al.  The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Klingelhutz,et al.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. , 2012, Virology.

[39]  Dong-Myung Shin,et al.  HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. , 2015, Carcinogenesis.

[40]  M. Ustav,et al.  Genomic instability of the host cell induced by the human papillomavirus replication machinery , 2007, The EMBO journal.

[41]  T. Lindahl Instability and decay of the primary structure of DNA , 1993, Nature.

[42]  T. Baker,et al.  Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. , 1991, Biophysical journal.

[43]  A. Laudanna,et al.  Protective effect of ascorbic acid in experimental gastric cancer: reduction of oxidative stress. , 2003, World journal of gastroenterology.

[44]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[45]  N. Coleman,et al.  HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome , 2016, Oncogene.

[46]  Shibo Li,et al.  Expression of HPV16 E5 produces enlarged nuclei and polyploidy through endoreplication. , 2010, Virology.

[47]  P. Duerksen-Hughes,et al.  Modulation of Apoptotic Pathways by Human Papillomaviruses (HPV): Mechanisms and Implications for Therapy , 2012, Viruses.

[48]  T. Mogensen Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses , 2009, Clinical Microbiology Reviews.

[49]  S. Vinokurova,et al.  Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract , 2004, Cancer Research.

[50]  P. Duerksen-Hughes,et al.  The Human Papillomavirus 16 E6 Protein Binds to Fas-associated Death Domain and Protects Cells from Fas-triggered Apoptosis* , 2004, Journal of Biological Chemistry.

[51]  S. Jiao,et al.  Functional Role of NRF2 in Cervical Carcinogenesis , 2015, PloS one.

[52]  P. Howley,et al.  Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. Kaufmann,et al.  Human papilloma virus type16 E6 deregulates CHK1 and sensitizes human fibroblasts to environmental carcinogens independently of its effect on p53 , 2009, Cell cycle.

[54]  S. Ullrich,et al.  JP-8 induces immune suppression via a reactive oxygen species NF-kappabeta-dependent mechanism. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[55]  D. Lowy,et al.  Maturation of Papillomavirus Capsids , 2005, Journal of Virology.

[56]  T. van Dyke,et al.  Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. , 2000, Carcinogenesis.

[57]  Masayuki Yamamoto,et al.  Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  P. Lambert,et al.  Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[59]  R. Mitra,et al.  The Papillomavirus E1 Helicase Activates a Cellular DNA Damage Response in Viral Replication Foci , 2011, Journal of Virology.

[60]  N. Wallace,et al.  HPV 5 and 8 E6 Abrogate ATR Activity Resulting in Increased Persistence of UVB Induced DNA Damage , 2012, PLoS pathogens.

[61]  Cary A Moody,et al.  Human Papillomaviruses Activate the ATM DNA Damage Pathway for Viral Genome Amplification upon Differentiation , 2009, PLoS pathogens.

[62]  J. Fruehauf,et al.  Reactive oxygen species: an Achilles’ heel of melanoma? , 2008, Expert review of anticancer therapy.

[63]  Harald zur Hausen,et al.  Papillomavirus infections — a major cause of human cancers , 1996 .

[64]  E. Wang,et al.  The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. , 2003, Virology.

[65]  I. E. Sánchez,et al.  Cysteine-rich positions outside the structural zinc motif of human papillomavirus E7 provide conformational modulation and suggest functional redox roles. , 2014, Biochemistry.

[66]  Leroy F. Liu,et al.  Hydrogen Peroxide Induces Topoisomerase I-mediated DNA Damage and Cell Death* , 2004, Journal of Biological Chemistry.

[67]  H. Pitot,et al.  Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. , 2007, Cancer research.

[68]  E. Androphy,et al.  The BPV-1 E2 DNA-contact helix cysteine is required for transcriptional activation but not replication in mammalian cells. , 1996, Virology.

[69]  M. Botchan,et al.  Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. , 1990, Science.

[70]  Y. Song,et al.  Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells. , 2010, Carcinogenesis.

[71]  A. Levonen,et al.  The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer☆ , 2013, Redox biology.

[72]  D. Wazer,et al.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.

[73]  P. Duerksen-Hughes,et al.  Chronic oxidative stress increases the integration frequency of foreign DNA and human papillomavirus 16 in human keratinocytes. , 2016, American journal of cancer research.

[74]  D. Fan,et al.  Regulation of apoptosis by the papillomavirus E6 oncogene. , 2005, World journal of gastroenterology.

[75]  A. Geetha,et al.  Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[76]  Donna D. Zhang,et al.  Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. , 2009, Molecular cell.

[77]  M. Rajappa,et al.  Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response , 2010, Molecular and Cellular Biochemistry.

[78]  S. Baratchi,et al.  Survivin Mutant Protects Differentiated Dopaminergic SK-N-SH Cells Against Oxidative Stress , 2011, PloS one.

[79]  Zhichong Wang,et al.  Increased Oxidative Stress as a Selective Anticancer Therapy , 2015, Oxidative medicine and cellular longevity.

[80]  Karl Münger,et al.  Biological activities and molecular targets of the human papillomavirus E7 oncoprotein , 2001, Oncogene.

[81]  Richard Schlegel,et al.  Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. , 2005, The Journal of general virology.

[82]  J. Harper,et al.  The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase , 2004, Molecular and Cellular Biology.

[83]  C. B. Pickett,et al.  Phosphorylation of Nrf2 at Ser-40 by Protein Kinase C Regulates Antioxidant Response Element-mediated Transcription* , 2002, The Journal of Biological Chemistry.

[84]  R. Schlegel,et al.  The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes. , 2010, Biochemical and biophysical research communications.

[85]  R. Roden,et al.  Tissue-Spanning Redox Gradient-Dependent Assembly of Native Human Papillomavirus Type 16 Virions , 2009, Journal of Virology.

[86]  Q. Ma,et al.  Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2 , 2012, Pharmacological Reviews.

[87]  Y. Song,et al.  Targeting Nrf2 Signaling to Combat Chemoresistance , 2014, Journal of cancer prevention.

[88]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[89]  R. Schlegel,et al.  The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein , 1993, Journal of virology.

[90]  Miranda Thomas,et al.  Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. , 1999, The Journal of general virology.

[91]  P. Duerksen-Hughes,et al.  Human Papillomavirus Type 16 E6* Induces Oxidative Stress and DNA Damage , 2014, Journal of Virology.

[92]  A. Phaniendra,et al.  Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases , 2014, Indian Journal of Clinical Biochemistry.

[93]  M. Botchan,et al.  The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. , 2004, Genes & development.

[94]  Masayuki Yamamoto,et al.  Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[95]  D. Pim,et al.  Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth , 1997, Oncogene.

[96]  A. Miyajima,et al.  Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. , 1997, British Journal of Cancer.

[97]  A. Kong,et al.  Epigenetic regulation of Keap1-Nrf2 signaling. , 2015, Free radical biology & medicine.

[98]  Alison A McBride,et al.  The papillomavirus E2 proteins. , 2013, Virology.

[99]  D. Wallace Mitochondria and cancer , 2012, Nature Reviews Cancer.

[100]  I. Fridovich,et al.  Free radicals in cutaneous biology. , 1994, The Journal of investigative dermatology.

[101]  R. Guérois,et al.  Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide Formation* , 2010, The Journal of Biological Chemistry.

[102]  Mihee M. Kim,et al.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.

[103]  T. Hupp,et al.  Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain , 2003, EMBO reports.

[104]  K. Münger,et al.  The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. , 2002, Cancer research.

[105]  M. Valko,et al.  Free radicals, metals and antioxidants in oxidative stress-induced cancer. , 2006, Chemico-biological interactions.

[106]  A. Di Pietro,et al.  Higher levels of oxidative DNA damage in cervical cells are correlated with the grade of dysplasia and HPV infection , 2016, Journal of medical virology.

[107]  Takafumi Suzuki,et al.  Molecular basis of the Keap1-Nrf2 system. , 2015, Free radical biology & medicine.

[108]  S. Giordano,et al.  The Dual Roles of NRF2 in Cancer. , 2016, Trends in molecular medicine.

[109]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[110]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.

[111]  Sandy S. Tungteakkhun,et al.  The Large and Small Isoforms of Human Papillomavirus Type 16 E6 Bind to and Differentially Affect Procaspase 8 Stability and Activity , 2007, Journal of Virology.

[112]  P. Piña-Sánchez,et al.  Expression of the HPV18/E6 oncoprotein induces DNA damage , 2017, European journal of histochemistry : EJH.

[113]  C. Demeret,et al.  Nucleo-cytoplasmic Shuttling of High Risk Human Papillomavirus E2 Proteins Induces Apoptosis* , 2005, Journal of Biological Chemistry.

[114]  D. Yoon,et al.  Protective effect of oxidative stress in HaCaT keratinocytes expressing E7 oncogene , 2007, Amino Acids.

[115]  Degenerate cysteine patterns mediate two redox sensing mechanisms in the papillomavirus E7 oncoprotein , 2016, Redox biology.

[116]  F. D. Marco,et al.  Oxidative Stress and HPV Carcinogenesis , 2013 .

[117]  L. Banks,et al.  The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8. , 2014, Virology.

[118]  R. Garcea,et al.  Interactions between Papillomavirus L1 and L2 Capsid Proteins , 2003, Journal of Virology.

[119]  E. Cadenas Basic mechanisms of antioxidant activity , 1997, BioFactors.

[120]  J. Kleibeuker,et al.  Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease , 1998, The Journal of pathology.

[121]  C. B. Pickett,et al.  The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress* , 2009, Journal of Biological Chemistry.

[122]  D. Patel,et al.  Human Papillomavirus Type 16 E6 and E7 Cause Polyploidy in Human Keratinocytes and Up-Regulation of G2-M-Phase Proteins , 2004, Cancer Research.

[123]  Tak Yee Aw,et al.  Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.

[124]  Do-Young Yoon,et al.  E7‐expressing HaCaT keratinocyte cells are resistant to oxidative stress‐induced cell death via the induction of catalase , 2005, Proteomics.

[125]  C. Harris,et al.  Radical causes of cancer , 2003, Nature Reviews Cancer.

[126]  S. Lowe,et al.  Tumor suppressive functions of p53. , 2009, Cold Spring Harbor perspectives in biology.

[127]  R. Cole,et al.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[128]  M. Stanley HPV - immune response to infection and vaccination , 2010, Infectious Agents and Cancer.

[129]  A. Stenlund,et al.  Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding , 2000, The EMBO journal.

[130]  Y. Rojanasakul,et al.  Inflammation and Lung Cancer: Roles of Reactive Oxygen/Nitrogen Species , 2008, Journal of toxicology and environmental health. Part B, Critical reviews.

[131]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[132]  R D Klausner,et al.  Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[133]  H. Bartsch,et al.  Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair , 2006, Langenbeck's Archives of Surgery.

[134]  A. McBride,et al.  Papillomavirus Genomes Associate with BRD4 to Replicate at Fragile Sites in the Host Genome , 2014, PLoS pathogens.

[135]  Shujuan Liu,et al.  Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer , 2012, Cancer Chemotherapy and Pharmacology.

[136]  N. Nalini,et al.  Evidence of oxidative stress in the circulation of ovarian cancer patients. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[137]  A. Venuti,et al.  HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness , 2002, Journal of medical virology.

[138]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[139]  D. McCance,et al.  The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes , 1995, Journal of virology.

[140]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[141]  M. Tania,et al.  Antioxidant enzymes and cancer , 2010 .

[142]  J. Pedraza-Chaverri,et al.  Human Papillomavirus Types 16 and 18 Early-expressed Proteins Differentially Modulate the Cellular Redox State and DNA Damage , 2018, International journal of biological sciences.

[143]  E. Tekle,et al.  Epidermal Growth Factor (EGF)-induced Generation of Hydrogen Peroxide , 1997, The Journal of Biological Chemistry.

[144]  Y. Pommier,et al.  Induction of Reversible Complexes between Eukaryotic DNA Topoisomerase I and DNA-containing Oxidative Base Damages , 1999, The Journal of Biological Chemistry.